The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

Investors could be overestimating the contribution of Hims & Hers' compounded GLP-1 medications to its top line. Read why I ...

Although the ‘disclaimer’ for the Hims & Hers ad was printed in ... to the soaring demand for these weight loss drugs, it’s now a mainstream phenomenon. Semaglutide has been on the market ...

The “Check Before You Inject” ad goes on to note that some vials of compounded semaglutide “have been found to contain ...

When celebrities reveal their experiences with newer weight-loss drugs, there are upsides and downsides for patients and ...

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help people drink less alcohol. A study published in JAMA Psychiatry enrolled 48 ...

Novo Nordisk A/S shares are on track for their worst week this year, after a Super Bowl advertisement touting copycat ...

Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site.The ad also hit a nerve with the ...

Exclusive: ASA calls number of parallel probes ‘significant’ and describes tackling issue as ‘priority’ after it issued ...

As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...

The past few days haven't been kind to most stocks in the white-hot obesity drugs space. One developer of a weight loss ...